Predictive performance of serum myostatin levels for development of HCC was higher in patients with age < 65 years old, male, and Child–Pugh class A as compared to those with age ≥ 65 years old, female, and Child–Pugh class B/C. The gene discussed is MSTN; the disease is hepatocellular carcinoma.